. The developmental decrease in rapid-eyemovement (REM) sleep in man occurs between birth and after puberty. We hypothesize that if this decrease in REM sleep does not occur, lifelong increases in REM sleep drive may ensue. Such disorders are characterized by hypervigilance and sensory-gating deficits, such as are present in postpubertal onset disorders like schizophrenia, panic attacks (a form of anxiety disorder), and depression. The decrease in REM sleep in the rat occurs between 10 and 30 days of age. We studied changes in size and physiological properties of pedunculopontine nucleus (PPN) cells involved in the control of arousal, i.e., waking and REM sleep. During the largest decrease in REM sleep (12-21 days), cholinergic PPN neurons doubled in cell area, the hypertrophy peaking at 15-16 days, then decreasing in area by 20 -21 days. Noncholinergic PPN cells did not change in area during this period. We confirmed the presence of two populations of PPN neurons based on action potential (AP) duration, with the proportion of short-AP-duration cells increasing and long AP duration decreasing between 12 and 21 days. Most cholinergic and noncholinergic cells had short AP durations. Afterhyperpolarization (AHP) duration became segregated into long and short AHP duration after 15 days. Cells with short AP duration also had short AHP duration. The proportion of PPN cells with I h current increased gradually, peaking at 15 days, then decreased by 21 days. These changes in morphological and physiological properties are discussed in relation to the developmental decrease in REM sleep.
I N T R O D U C T I O N
The human newborn exhibits an even distribution of waking, rapid-eye-movement (REM) sleep and slow-wave sleep (SWS), spending ϳ8 h in each state, a process controlled by the mesopontine reticular-activating system (RAS). There follows a gradual decrease in REM sleep from ϳ8 h at birth to ϳ1 h by 20 yr of age, beyond which there is a mild decrease until senescence (Roffwarg et al. 1966) . It has been suggested that REM sleep has the biological function of serving to direct the course of brain maturation (Marks et al. 1995) . This is in keeping with evidence suggesting that activity-dependent development may be a widespread mechanism directing neural connectivity throughout the brain (Llinas 1984; Marks et al. 1995) . High-frequency mesopontine activation, especially in the form of ponto-geniculo-occipital (PGO) waves, could contribute to the maturation of ascending RAS-induced activation of thalamocortical pathways (Marks et al. 1995) . A similar effect could be in place in terms of descending RAS projections, given recent results suggesting that spontaneous muscle twitches during sleep help guide spinal self-organization (Petersson et al. 2003) . We hypothesized that if this developmental decrease in REM drive does not occur by the end of puberty, lifelong increases in REM sleep drive may ensue . That is, such a mechanism may be responsible for the postpubertal onset in humans of a number of disorders marked by increased REM sleep drive, including schizophrenia, anxiety disorder, and (bipolar) depression (Garcia-Rill 1997) .
In the rat, the developmental decrease in REM sleep occurs between 10 and 30 days of age, declining from Ͼ70% of total sleep time at birth to ϳ15% of sleep time by 30 days of age (Jouvet-Mounier et al. 1970) . The pedunculopontine nucleus (PPN), as the cholinergic arm of the RAS, is known to modulate waking, REM sleep, and PGO waves. PPN neurons, which can be cholinergic or noncholinergic, increase their firing rates during synchronization of fast rhythms in waking and in REM sleep (i.e., show tonic activity in waking, bursting activity during REM sleep, and reduced activity during slow wave sleep) (Sakai et al. 1990; Steriade et al. 1990a Steriade et al. ,b, 1996 . Steriade has described at least six different types of PGO wave-related neurons in the region of the PPN (Steriade et al. 1990a) . The presence of "REM-on," "REM-off," and "Wake-REM-on" cells in the region of the PPN (although these have not been identified as cholinergic or noncholinergic) also has been reported (see review by Datta 1995; and activity patterns across the sleep-wake cycle in rats in Datta and Siwek 2002) .
Morphologically, PPN neurons change markedly from birth to 30 days of age in the rat. Mean cell area increased from ϳ200 m 2 at 10 days of age, to Ͼ600 m 2 at ϳ15 days, then decreased to the adult area of ϳ300 m 2 by 30 days of age (Skinner et al. 1989 ). The hypertrophy observed was ascribed to developmental hallmarks related to the time of eye and ear opening at ϳ15 days of age in the rat (Kungel et al. 1996; Sheets et al. 1988 ). This phenomenon was accompanied by increased labeling attributed to changes in the production of structural proteins and of enzymes involved in metabolic events, axonal growth, and synaptogenesis ϳ15 days of age. The subsequent decrease in mean cell size did not appear to be due to selective loss of large cells but rather to overall cell shrinkage (Skinner et al. 1989 ). A recent report described an increase in choline acetyltransferase activity during the developmental decrease in REM sleep percent in the rat (Ninomiya et al. 2001) , simultaneously with the hypertrophy described previously.
We have been studying the changes in PPN neuronal properties, synaptic inputs, and neurochemical control during the most rapid decrease in REM sleep in the rat, 12-21 days postnatally. This work in brain stem slices has revealed important principles that may apply to developmental regulation of arousal and sleep-wake cycles at the cellular level. For example, we recently described the presence of a decrease in Nmethyl-D-aspartic acid (NMDA) responses in intracellularly recorded PPN neurons during this period with a concomitant increase in kainic acid (KA) responses over the same time (Kobayashi et al. 2004 ). The shift from NMDA to KA predominance occurred at ϳ15 days. Between 12 and 21 days, we also found gradually increasing inhibitory responses to a serotonergic (5-HT) type 1 receptor agonist in PPN neurons . The present findings describe morphometric and electrophysiological changes during this period in development in PPN neurons identified as cholinergic or noncholinergic. The changes observed over the developmental decrease in REM sleep may be of considerable clinical importance given the critical nature of this period in development and the hypothesis outlined in the preceding text.
M E T H O D S

Subjects
Timed-pregnant Sprague-Dawley rats (280 -350 g) were used, and the litters were culled to 10. At 12-21 days of age, pups were anesthetized using ketamine (70 mg/kg im) until tail pinch and corneal reflexes were absent and were rapidly decapitated. The brains were dissected free under cooled (4°C), oxygenated (95% O 2 -5% CO 2 ) artificial cerebrospinal fluid (ACSF), and semi-horizontal brain stem slices were cut along the long axis of the PPN for recording of developmental changes in local properties. The block of tissue was glued onto a stage and 400 m slices cut with a Vibroslicer (Campden Instruments) under cooled, oxygenated ACSF, and then allowed to equilibrate for 1 h in oxygenated ACSF at room temperature before recording. The composition of the ACSF was (in mM) 122.8 NaCl, 5 KCl, 1.2 MgSO 4 , 2.5 CaCl 2 , 1.2 NaH 2 PO 4 , 25 NaHCO 3 , and 10 dextrose. Only 1-2 of the 400-m slices from each brain contained the PPN. We used 150 pups to generate the data described herein. All animal use procedures were approved by the Institutional Animal Care and Use Committee.
Recording procedures
The recording chamber allowed the slice to be suspended on a nylon mesh so that oxygenated ACSF could flow evenly around the slice. The gravity-fed ACSF flowed through a sleeve of circulating warmed water so that the temperature of the ACSF in the chamber was 30 Ϯ 1°C (mean Ϯ SD). The outflow was removed by suction and the flow adjusted to 2-3 ml/min. Microelectrodes were pulled in a Sutter Instruments puller using Omega-Dot, thin-wall borosilicate glass and filled with 3 M K ϩ acetate and 1% biocytin and had a resistance of 70 -90 M⍀. Signals were amplified with an Axoclamp 2B amplifier (Axon Instruments, Foster City, CA) in current-clamp mode. Neurons were impaled and allowed to stabilize for ϳ5 min before testing. Neurons that showed a stable resting membrane potential (RMP) up to Ϫ50 mV and action potentials Ն45 mV and that had stable, long-term recordings were accepted for data analysis. The RMPs were verified and adjusted when the electrode was withdrawn at the end of recordings (usually only 1-2 mV difference, sometimes Ͼ5 mV especially after biocytin injection). In bridge mode, a series of hyperpolarizing and depolarizing current steps of 0.1-1.0 nA at RMP were applied to determine membrane properties. These current steps also allowed the computation of a preliminary I-V curve during the linear range of voltage deflections using SuperScope software (GW Instruments).
Stimulation procedures
Neuroactive agents could be applied via a manifold with perfusion ports, hence multiple gravity-fed solutions could be applied for pharmacological characterization of neuronal properties. The agents superfused in these studies were the I h current blocker ZD7288 (Chevaleyre and Castillo 2002; Luthi et al. 1998) , at a concentration of 10 M, and the sodium channel blocker tetrodotoxin (TTX), at a concentration of 0.3 M. Superfusion was performed for 1 min, then the bath was allowed to wash out so that recovery could be assessed.
Physiological identification
The presence of three types of PPN neurons was reported in the guinea pig, namely neurons with a low-threshold spike (LTS; type 1), an A current (type 2), and both AϩLTS (type 3) (Leonard and Llinas 1990) . Most type 2 and 3 neurons were identified as cholinergic. It should be noted that even newborn guinea pigs show adult-like REM sleep percent, so that their REM sleep drive is more like that of the adult rat, and they undergo no major changes in sleep/wake control across postnatal development (Jouvet-Mounier et al. 1970) . As far as the rat is concerned, there appears to be agreement across laboratories that there are three types of PPN neurons, type I (LTS, noncholinergic), type II (A, 2/3 cholinergic) and type III (AϩLTS, 1/3 cholinergic) (Kamondi et al. 1992; Kang and Kitai 1990; Leonard and Llinas 1990; ). Therefore we first determined electrophysiologically the type of PPN neuron being studied, injected it intracellularly, and later confirmed whether it was cholinergic or not.
Anatomical identification
At the end of the recording period, each neuron was injected with biocytin using intracellular depolarizing pulses adjusted to elicit a train of action potentials (0.5-1.0 nA) of 500-ms duration at 1 Hz for 10 -15 min. Such injections yielded well-filled neurons. All of the slices were first processed for Texas Red-avidin immunocytochemistry (for viewing using fluorescence microscopy) by incubating the slices in Texas Red-avidin for 3 h, and then processed for NADPH diaphorase histochemistry (for viewing using light microscopy) for selective labeling of cholinergic mesopontine (PPN) neurons (Vincent et al. 1983) . Briefly, slices were fixed in 4% buffered paraformaldehyde for 1-2 h, cryoprotected in 20% sucrose, and cut in a cryostat at 50 m. Sections were incubated in 1 mg/ml NADPH and 0.1 mg/ml nitroblue tetrazolium in PBS at 37°C for 30 -60 min. Double-labeled neurons were assumed to be cholinergic PPN cells. Texas-Red-labeled NADPH diaphorase-negative cells were assumed to be noncholinergic PPN cells as long as they were in the vicinity of NADPH-diaphorasepositive (cholinergic PPN) cells. We used a Nikon image-analysis system with Metamorph software to measure cell areas.
Statistical procedures
For comparison of data between the different age groups and cell types in each experiment, measures were tested using one-, two-, or multifactor ANOVA to conclude whether any of the factors (e.g., age) had a significant effect on the magnitude of the measure (e.g., action potential duration) and also whether the interaction of the factors significantly affected the measure (age vs. duration). Differences were considered significant at values of P Յ 0.05. If a statistical significance was present, a post hoc test (Newman-Keuls) was used to compare between groups. In simple cases comparing two groups, unpaired t-test were used. Distributions also were compared using a 2 test. Correlations were tested using a Pearson's correlation test.
R E S U L T S
Mean cell area Figure 1 shows representative neurons recorded in these studies. In A, the fluorescence microscopy frame shows the Texas Red-avidin labeling of the intracellularly injected neuron, while the light microscopy inset shows the NADPH diaphorase labeling of the same neuron. This was assumed to be a cholinergic PPN neuron. In B, the fluorescence microscopy frame shows another Texas Red-avidin labeled (biocytin-injected) neuron, and the light microscopy frame shows that this neuron was not NADPH-diaphorase-positive, although other cells in the region were NADPH-diaphorase-positive. Therefore this neuron was assumed to be a noncholinergic PPN neuron. Of the 154 PPN cells recorded and identified for these measures, 103 cells were cholinergic and 51 were noncholinergic using these criteria. Figure 2 is a graph of the average (mean Ϯ SE) cell area (in m 2 ) at each age of all of the neurons studied segregated into cholinergic (F) and noncholinergic (ᮀ). The cholinergic PPN cell areas increased from the 12-day size of 384 Ϯ 20 to a peak of 693 Ϯ 34 m 2 by 15 days, before decreasing in size to 448 Ϯ 23 m 2 by day 21. Repeated-measures ANOVA and post hoc testing across age indicated that cholinergic PPN neuronal area was significantly (df ϭ 9, F ϭ 10.3, P Ͻ 0.001) greater at 14, 15, 16, and 17 days compared with 12, 20, and 21 days. On the other hand, the noncholinergic cells recorded showed areas of 334 Ϯ 35 m 2 at 12 days, 412 Ϯ 29 m 2 at 15 days, and 382 Ϯ 19 m 2 at 21 days. Repeated-measures ANOVA showed that there was no statistical difference (df ϭ 7, F ϭ 1.27, NS) in noncholinergic cell area across age. Fewer cholinergic and no noncholinergic cells were recorded at days 16 or 17 due to limited sampling on those days.
When one-way ANOVA was used to compare cholinergic versus noncholinergic neurons at individual ages, there was a statistically significant (range of F values ϭ 30.11-10.46, P Ͻ 0.001) increase in cell area for cholinergic neurons compared with noncholinergic cells at 13, 14, 15, 18, and 19 days. FIG. 2. Mean cell area across age for cholinergic and noncholinergic PPN neurons. F, the mean Ϯ SE of the cell area of biocytin-injected, Texas Red-avidin-positive, NADPH-diaphorase-positive, i.e., cholinergic, PPN neurons at each age studied. ᮀ, the mean Ϯ SE of the cell area of biocytin-injected, Texas Red-avidin-positive, NADPH-diaphorase-negative, i.e., noncholinergic, PPN neurons at each age studied. These means are listed in Table 2 . At 12 days, the areas of cholinergic and noncholinergic cells were not statistically different but did differ statistically until day 19 (**P Ͻ 0.01). On day 20, they no longer differed statistically, but on day 21, they were marginally different (*P Ͻ 0.05).
However, they did not differ in mean cell area at the beginning of the period studied (12 days, P ϭ 0.31, NS) or toward the end (20 days, P ϭ 0.12, NS). Interestingly, there was a statistically significant (although marginal) difference in cell area at 21 days with cholinergic neurons being slightly larger than noncholinergic neurons (P ϭ 0.049). No comparisons could be made at 16 and 17 days.
APs
Previous studies had described the presence of two populations of type 2 (A current, 2/3 cholinergic) PPN neurons Ͼ30 days of age based on their action potential durations, namely 0.7-1.5 and 1.6 -2.9 ms . We undertook a study of action potential durations of type 2 PPN neurons across the critical period in development of 12-21 days. Table 1 lists the means Ϯ SE of the action potential durations of type 2 PPN neurons. As previously described, the action potential durations of these cells fell into two groups, a short-and a long-AP-duration group based on the preceding durations. When these type 2 neurons were divided into cholinergic and noncholinergic cells, we found that the overwhelming majority of cholinergic neurons had short AP duration (58/60, 95%) and only few had long AP duration (5%). Most noncholinergic neurons (21/26, 80%) also had short AP duration compared with long AP duration (20%). Figure 3 is a graph of the AP durations of the short-versus long-AP-duration groups over age. In Fig. 3A , we plot the short-versus long-duration-AP cells by age, showing that there is no change across age in the mean duration of short versus long AP durations. Representative examples of short-versus long-duration type 2 PPN neurons are shown on the right. Note the difference in AP duration but the similarity in the presence of an A current in both groups. In Fig. 3B , we plot the percentage of short-versus long-AP-duration type 2 PPN neurons over age. This graph shows that although mean AP duration did not change over age, the percentage of long-APduration cells decreased over age, whereas the percentage of short-AP-duration cells increased over age. The distributions of short-versus long-AP-duration neurons over age (2-day epochs) were compared using a 2 test and found to be statistically different (df ϭ 4, 2 ϭ 42.1, P Ͻ 0.001). A final analysis on the AP in these neurons was the mean firing frequency induced by depolarizing steps in short-versus long-AP-duration neurons. Depolarizing steps of ϩ0.5 nA induced a mean firing frequency of 32.4 Ϯ 3.9 Hz in short-AP-duration cells, but a statistically (unpaired t-test, df ϭ 64, t ϭ Ϫ2.44, P Ͻ 0.02) lower firing frequency of 24.0 Ϯ 1.3 Hz in long-AP-duration cells. Depolarizing steps of ϩ0.9 nA induced a firing frequency of 39.6 Ϯ 5.9 Hz in short-APduration cells and 43.5 Ϯ 2.9 Hz in long-AP-duration cells, but the difference was not statistically significant (unpaired t-test, df ϭ30, t ϭ 0.43, NS).
AHP
The distribution of mean AHP durations over age was stable but with a great deal of variability (Fig. 4) . For example, the mean AHP duration in 12-to 15-day cells versus 16-to 21-day cells was not statistically different, but there appeared to be a segregation of AHP duration into two populations. When cholinergic and noncholinergic cells together were considered, PPN neurons aged 16 -21 days had either long AHP duration (239 Ϯ 6 ms) or short AHP duration (86 Ϯ 10 ms; ANOVA df ϭ 45, F ϭ 169.6, P Ͻ 0.0001). Regression analysis of these two populations showed that the slopes of the best-fit lines describing the AHP duration had diverging slopes with age. Long-AHP-duration cells had an r value of 0.89 and short-AHP-duration neurons had an r value of 0.71. That is, after day 16, there was a gradually increasing difference in AHP duration between the two populations of type 2 cells, indicative of a marked change in potential firing rate after 15 days. We then divided these cells into cholinergic and noncholinergic neurons. Cholinergic cells 12-15 days showed a mean AHP duration of 131 Ϯ 10 ms (n ϭ 40), whereas noncholinergic cells had an AHP duration of 129 Ϯ 16 ms (n ϭ 29), i.e., were not statistically different. Similarly, 16-to 21-day cholinergic cells had an AHP duration of 126 Ϯ 12 ms (n ϭ 58), whereas noncholinergic cells were 139 Ϯ 15 ms (n ϭ 19), again, not different.
However, Fig. 4A is a graph of the individual AHP durations of cholinergic PPN cells showing the apparent segregation of these neurons into two nonoverlapping populations based on AHP duration. There were no AHP durations between 127 and 170 ms in 16-to 21-day cholinergic cells. We pooled these groups into Ͻ150 and Ͼ150 ms durations. The short-AHPduration cells had an average AHP duration of 66 Ϯ 5 ms (n ϭ 36) and the long-AHP-duration of 225 Ϯ 12 ms (n ϭ 22), and these were statistically different (F ϭ 3.44, P Ͻ 0.001). The best-fit lines showed divergent slopes (Fig. 4A) . On the other hand, 16-to 21-day noncholinergic cells showed no AHP durations between 110 and 140 ms. Arbitrarily dividing these into Ͻ125-and Ͼ125-ms durations again revealed two populations (short AHP: 82 Ϯ 8 ms, n ϭ 9; long AHP: 191 Ϯ 14 ms, n ϭ 10; F ϭ 3.62, P Ͻ 0.001). However, noncholinergic PPN cells aged 16 -21 days showed convergent slopes of AHP durations (Fig. 4B) .
The segregation into long and short AHP duration was related to the long and short AP duration described in the preceding text. There was no correlation between AP duration and AHP duration for cells aged 12-15 days. Pearson's correlation for cells on the Fig. 4 , left, showed no significant correlation between AP and AHP duration (df ϭ 42, F ϭ 1.51, NS). However, for cells aged 16 -21 days, there was a significant correlation between AP duration and AHP duration (df ϭ 45, F ϭ 12.76, P Ͻ 0.001). Basically, for cells 16 -21 days of age, long-AHP-duration cells (239 Ϯ 31 ms) also had long AP durations (1.8 Ϯ 0.8 ms) and short-AHP-duration cells (86 Ϯ 47 ms) also had short AP durations (1.0 Ϯ 0.6 ms). This relationship may be straightforward because a prolongation in the AP duration may allow additional calcium entry during repolarization, thus improving the likelihood of activating the long-duration AHP mechanism. Previous studies found that a subpopulation of type 2 (A) cells can fire faster at ϳ10 Hz in pacemaker fashion (Leonard and Llinas 1990) . We suspect that these may include more short-AHP and -AP-duration neurons. These properties imply that the period ϳ15 days of age is a transition time between lower compared with higher firing rates in at least some type 2 PPN neurons.
I h current
I h is a noninactivating inward cation current carried by sodium/ potassium ions with a -30 to -50 mV reversal potential that slowly activates during hyperpolarization. I h channels have been postulated to contribute to the resting membrane potential (some of these channels are open at RMP) and control rhythmic firing in spontaneously active cells (McCormick and Pape 1990) . These channels are regulated by cyclic nucleotides (DiFrancesco 1993), which may affect neuronal excitability and rhythmicity in CNS neurons (Pape and McCormick 1989) , especially in thalamic neurons Soltesz et al. 1991) . We analyzed the presence of I h in type 2 PPN neurons over age. Figure 5A shows the percentage of type 2 PPN neurons with and without I h current. There was a gradual increase in the percentage of cells with I h across age, with a concomitant decrease in cells without I h , from 12 through 17 days. After that time, the percentage of cells with I h decreased and remained at that level. A number (n ϭ 6) of FIG. 4. Afterhyperpolarization (AHP) duration across age. A: AHP in cholinergic type 2 PPN cells. E, a homogeneous distribution of AHP durations for 12-15 day cells with mean of 131 Ϯ 10 (SE) ms (n ϭ 40), whereas the mean for 16 -21 days was 126 Ϯ 12 ms (n ϭ 58). However, there appeared to be 2 discernible populations of 16-to 21-day cells. When these were pooled into AHP durations Ͻ150 ms vs. those with AHP durations Ͼ150 ms, they were significantly different (long AHP duration: 225 Ϯ 12 ms, n ϭ 22, vs. short AHP duration: 66 Ϯ 5 ms, n ϭ 36; F ϭ 3.44, P Ͻ 0.01). ϫ, short-duration-AHP neurons; OE, long-duration-AHP neurons. The best fit lines for the long-vs. short-duration-AHP cells 16 -21 days of age showed diverging slopes with age, indicating that there may be 2 populations of cells with increasingly different AHP durations. B: AHP in noncholinergic type 2 PPN cells. E, a homogeneous distribution of AHP durations for 12-to 15-day cells with a mean of 129 Ϯ 16 ms (n ϭ 29), whereas the mean for 16 -21 days was 139 Ϯ 15 ms (n ϭ 19). These cells were divided into short vs. long duration AHP (͗125͘ ms). While the means did show a statistically significant difference (long AHP duration: 191 Ϯ 14 ms, n ϭ 10, vs. short AHP duration: 82 Ϯ 8 ms, n ϭ 9; F ϭ 3.62, P Ͻ 0.01), the best fit lines converged, indicating that there may be a convergence toward short AHP durations in noncholinergic type 2 PPN cells.
neurons were tested using the I h blocker ZD7288, in which the current was blocked in ACSF and in the presence of TTX (Fig.  5B) . As can be observed in this figure, the presence of TTX eliminated the action potential generated by the release from hyperpolarization and depolarization at the end of the A current. The I h was blocked on addition of the blocker ZD7288; however, it should be noted that the A current was also blocked, indicating that this blocker may not be specific to I h channels but perhaps also block other cation currents at least in PPN neurons. The amplitude of the hyperpolarizing pulses did not change after TTX exposure (not shown) but increased in amplitude after ZD7288, indicating the blockade of some current, presumably a cation current. The mean input resistance (R in ) increased from 93 Ϯ 18 M⍀ before to 119 Ϯ 24 M⍀ after, ZD7288. This increase in R in was not statistically different (ANOVA df ϭ 11, F ϭ 0.73, NS); however, it represented a 28% increase in resistance.
A final analysis on these neurons was the mean firing frequency induced by depolarizing steps in I h -positive versus I h -negative neurons. Depolarizing steps of ϩ0.5 nA induced a mean firing frequency of 29.7 Ϯ 1.4 Hz in I h -positive cells but a statistically (unpaired t-test, df ϭ 130, t ϭ Ϫ3.6, P Ͻ 0.0001) lower firing frequency of 20.5 Ϯ 2.5 Hz in I h -negative cells. Depolarizing steps of ϩ0.9 nA induced a statistically higher (unpaired t-test, df ϭ 30, t ϭ 12.5, P Ͻ 0.001) firing frequency in I h -positive cells (48.6 Ϯ 3.4 Hz) compared with I h -negative cells (31.0 Ϯ 2.9 Hz).
Other properties
The present studies also addressed a number of basic cell properties that did not change over age, and these are provided in Fig. 6 . A group of 90 recorded neurons were pooled because there were no differences in any of the following measures between cholinergic and noncholinergic PPN neurons. Briefly, resting membrane potential (RMP) did not change in these type II neurons across the period tested (Ϫ61.3 Ϯ 0.7 mV), R in likewise did not change (116.0 Ϯ 5.6 M⍀ over age, and neither did AP amplitude (60.2 Ϯ 0.7 mV) or AHP amplitude (15.5 Ϯ 0.5 mV). No trends in any of these measures were detected at the critical transition age of 15-16 days.
D I S C U S S I O N
Changes in cell size
The most comprehensive previous study of developmental changes in PPN cell size was based on measurement of some 10,000 cells and was restricted to NADPH-diaphorase-labeled cells (Skinner et al. 1989) . In that study, mean cell area was 391 m 2 at 12-14 days of age, whereas our present results from intracellularly injected NADPH-diaphorase-positive cells showed a mean area of 385 m 2 at 12 days, increasing to 549 m 2 at 13 days and 652 m 2 at 14 days (Table 2) . That is, cell size was similar at the beginning of the period studied, but there was a larger increase in size with age in injected cells. Similarly, the previous study showed a mean cell area to be 498 m 2 at 15-17 days, whereas the current study found mean area to be larger and stable at 694 m 2 at 15 days, 679 m 2 at 16 days, and 654 m 2 at 17 days. Therefore while the hypertrophy during this period was evident in both studies, the cell area increase was greater in the intracellularly injected cells. While it seems logical to expect injected cells to become swollen by dye injection, there was no dramatic change in cell size in intracellularly injected noncholinergic cells (Fig. 2, ᮀ) . It appears that, although the hypertrophy in cholinergic PPN neurons was evident during this period in development and mean cell area was comparable at the beginning of this epoch (12 days), the injected cholinergic cells tended to increase more in size. It is possible that the hypertrophy observed indicates a period of rapid intracellular structural flux that may have made the cells more amenable to swelling with injection than when cell size had stabilized later (after 17 days) during the period studied. Interestingly, cell area decreased to 461 m 2 by 21-23 days in the previous study, whereas the current work revealed a similar mean area of 448 m 2 at 21 days, i.e., a virtually identical regression in cell size. This suggests that injection at this age did not produce excessive swelling. Therefore at present, we cannot completely account for the larger average areas of injected cells (compared with histochemical labeling) during the peak of the hypertrophy in injected cells. Moreover, this effect was evident only in cholinergic, not noncholinergic, cells, suggesting that differences in fixation procedures and the like did not account for the difference.
Moreover, the previous study on PPN cell size employed a mathematical technique developed for skewed distributions modeled by a Weibull function (Skinner et al. 1989 ). This analysis determined that the hypertrophy observed at 15-17 days indicated a generalized growth followed by shrinkage of most cells and did not represent a selective loss of the largest cells. Our current sample size does not permit us to carry out such an analysis, but we assume that the same principles apply, i.e., the decrement in area by 21 days is due to overall size shrinkage not selective loss of large cells.
The hypertrophy, as stated in the preceding text, was limited FIG. 6. Type 2 PPN cell properties across age (n ϭ 90). A: RMP. RMP over age for all cells studied showed no significant changes across age. B: input resistance (R in ). R in for all of the cells studied did not show significant differences across age. C: AP amplitude. AP amplitude did not show significant differences across age. D: AHP amplitude. AHP amplitude did not show significant differences across age. When each of the preceding measures were computed for cholinergic vs. noncholinergic cells, there were no statistically significant differences between cell type and basic properties. to cholinergic cells, whereas noncholinergic neurons did not change significantly in size across this period. At 21 days, however, cholinergic cells did show a marginally greater mean cell area compared with noncholinergic cells. This difference was statistically significant, perhaps because of the lower (than at other ages) variance in each of the populations at 21 days. Previous studies on adult or juvenile rats have shown that there is no major difference in cell size between cholinergic and noncholinergic PPN neurons (Spann and Grofova 1992) or between intracellularly studied type 2 cholinergic and noncholinergic PPN cells (Takakusaki et al. 1996) . Our results also suggest that, after 19 days, any differences between these neurons in terms of area will be minor. Why is there a selective hypertrophy of PPN cholinergic neurons around 15 days? The marked changes in cell area could be related to developmental highlights marking eye and ear opening coupled with increased sensory input (Kungel et al. 1996; Sheets et al. 1988 ). However, the hypertrophy is exclusively in cholinergic neurons, suggesting that a transient yet specific change in cholinergic cell size is present in the PPN at this time. A transient increase in neuronal cell size in the second and third postnatal weeks has been reported in the neighboring locus coeruleus (Shimizu and Imamoto 1970; Sievers et al. 1981) . This phenomenon was attributed to changes in the production of structural proteins and of enzymes involved in metabolic events. The increased NADPH diaphorase labeling previously observed in PPN cells was ascribed to similar processes (Skinner et al. 1989 ). However, these metabolic events may be more related to output functions such as axonal growth and synaptogenesis, rather than to changes in inputs to PPN neurons, as the discussion in the following text will propose.
Changes in cell properties
The presence of short-and long-AP-duration PPN neurons has been described previously , but the fact that there is a developmental shift toward a greater proportion of short AP durations at ϳ15 days of age is novel. Most cholinergic and noncholinergic PPN neurons exhibited this shift. This suggests that AP duration detected extracellularly should not be used as a method for identifying cholinergic versus noncholinergic PPN cells. In addition, our results show a segregation of AHP durations after 15 days into short-and long-AHP-duration populations but only in cholinergic cells. From a functional viewpoint, longer-duration AHPs would be expected to lead to decreasing firing rates in cholinergic neurons, which may contribute to a decrease in REM sleep duration. Such a decrement in firing rate would be less significant in noncholinergic neurons because they showed a trend toward decreasing AHP duration. Taken at face value (and considering the relatively small sample size), a tentative conclusion may be that cholinergic neurons contribute more to the decrement in REM sleep duration than noncholinergic neurons.
Significantly, the populations of short-AP-and short-AHPduration neurons were correlated, suggesting that, after 15 days, there is a gradual trend toward a large population of cholinergic and noncholinergic PPN neurons that have faster firing properties. This relationship may be straightforward because a prolongation in the AP duration may allow additional calcium entry during repolarization, thus improving the likelihood of activating the long-duration-AHP mechanism. The fact that cells with short AP duration also had short AHP duration is a generalized finding evident in cortical neurons during natural sleep-wake states (Steriade et al. 2001) . Previous studies found that a subpopulation of type 2 (A) PPN cells can fire faster at ϳ10 Hz in pacemaker fashion (Leonard and Llinas 1990) , a manifestation evident during natural sleep-waking states (Steriade et al. 1990b) . We suspect that these may include more short-AP-and -AHP-duration neurons. These properties imply that the period ϳ15 days of age is a transition time between lower compared with higher firing rates in at least some type 2 PPN neurons. Interestingly, however, these changes in AP and AHP duration gradually increased or decreased but did not show an inverted U distribution as did cell area.
The most common excitatory transmitter in the PPN is glutamate. Recent studies have revealed that injection of glutamate into the PPN increased both waking and REM sleep in freely moving rats (Datta 2002) . Injections of NMDA induced a selective increase in waking, whereas injections of kainic acid induced a selective increase in REM sleep. We reported that the depolarization induced by NMDA on cholinergic PPN neurons gradually decreased between 12 and 21 days, whereas the depolarization induced by kainic acid on these neurons gradually increased over the same period (Kobayashi et al. 2004) . The shift from NMDA to kainic acid regulation occurred at ϳ15 days. These data imply that the control of REM sleep comes under the predominant influence of kainate receptors. It is unclear if the gradually increasing capacity for faster firing in cholinergic PPN neurons discussed in the preceding text is directly related to the gradually increasing kainic acid modulation of these cells over the same time period. Additional research will be needed to establish a functional link between these events.
I h currents are generated by hyperpolarization-activated, cyclic nucleotide-gated channels (HCNs), and the channel proteins are encoded by at least four HCN genes (HCN1-HCN4) (see a recent review by Santoro and Baram 2003) . The four homomeric channels differ such that activation and deactivation is fastest for HCN1 and slowest for HCN4. HCN1 is found mainly in cortex, whereas HCN4 is found subcortically. We assume that PPN neurons have at least some HCN4 channels, although this needs to be confirmed using, for example, in situ hybridization. Interestingly, I h proteins in the hippocampus, the most studied structure, are differentially regulated during development (Bender et al. 2001; Vasilyev and Barish 2002) . Originally, HCNs were thought to regulate rhythmic activity (Santoro and Baram 2003) . These proteins are in turn regulated by neuronal, especially paroxysmal, activity in the hippocampus (Brewster et al. 2002) and may contribute to paroxysmal activity in cortical cells (Timofeev et al. 2002) . Their role in PPN activity is unknown, so that future studies will require determination of changes in immunoreactivity of the various subunits across age in the PPN. We speculate that the increase in the proportion of cells showing I h around 15 days compared with lower proportions before and after that time, may indicate an increase in expression, perhaps mediated by increased PPN cell activity.
Significantly, noradrenergic and serotonergic inputs can modulate thalamic (Pape and McCormick 1989) and hippocampal (Poolos et al. 2002) h-channels. PPN neurons also receive noradrenergic and serotonergic inputs. We have found that during the developmental decrease in REM sleep, serotonergic type 1 agonists induced less hyperpolarization early (12-13 days) than later (20 -21 days) . On the other hand, serotonergic type 2 agonists hyperpolarized a minority of cholinergic PPN neurons and only marginally in those affected, whereas hyperpolarizing most noncholinergic neurons significantly (Kobayashi et al. 2004 ). However, these effects did not change during the developmental decrease in REM sleep. This suggests that serotonergic type 1 receptors exercise a gradually increasing inhibition on PPN firing during the developmental decrease in REM sleep, but serotonergic type 2 receptors may not be related to this event. Preliminary results showed that the noradrenergic alpha-2 receptor agonist clonidine had the opposite effect on developing PPN neurons, inducing more hyperpolarization early than late during this period in development (K. Mamiya, R. D. Skinner, and E. Garcia-Rill, unpublished data). It is clear, however, that noradrenergic and serotonergic inputs to cholinergic PPN neurons do not show a transient effect around 15 days, rather a gradually increasing or decreasing effect over the period tested (12 through 21 days).
A comparison of Figs. 2 and 5B reveals that cell size and the proportion of cells with Ih appear to change in parallel, in an inverted-U pattern (not gradually increasing or decreasing) peaking ϳ15 days. Moreover, the presence of I h expectedly led to higher firing frequencies being induced in I h -positive cells after depolarizing pulses (compared with I h -negative cells). These factors suggest that I h may contribute to increased levels of activity in PPN neurons, especially around the peak of the hypertrophy around 15 days. All of these factors lend support to the suggestion that it is PPN output, specifically cholinergic output, that is increasing transiently ϳ15 days. This hypothesis should be testable by determining if there is increased release of acetylcholine in the thalamus at ϳ15 days compared with before or after that time.
Clinical implications
We proposed that if the developmental decrease in REM drive does not occur, lifelong increases in REM sleep drive may ensue . Could dysregulation of any of the developmental changes described herein be responsible for inducing increases in REM sleep drive? We suspect that the gradually in creasing or decreasing changes observed in AP and AHP duration during the 12-to 21-day period may not influence REM sleep drive to a significant extent. On the other hand, the hypertrophy and increases in percent of cells with I h observed, which we suspect is related to a transient increase in PPN output at ϳ15 days, could lead to changes in REM sleep drive, particularly if such an effect is reinstated later in life due to pathological processes. Such an event would increase activity-dependent transcriptional factors such as the expression, or overexpression, of proteins like HCNs. This could lead to increased bursting or even paroxysmal activity. PPN cells are known to burst during REM sleep, but then only some types of PGO wave-related cells burst, whereas most PPN cells fire tonically especially during the steady REM sleep state (Steriade et al. 1990b ). Only a small percentage of PPN cells actually generate such bursting, and then only in relation to PGO waves, perhaps influencing distant sites known to generate PGO waves (Datta 1997; Datta et al. 1998) .
In schizophrenia, anxiety disorders, and bipolar and unipolar depression, increased REM sleep drive (increased REM duration, decreased REM latency, hypervigilance, etc., usually coupled with decreases in slow wave sleep) is a major, incapacitating symptom (Garcia-Rill 1997 . One plausible idea is that this effect represents a regression to a previous developmental state. Interestingly, most patients with schizophrenia, bipolar depression, male obsessive-compulsive disorder (OCD), and panic attacks develop the disorder postpubertally [ϳ80% between the ages of 15 and 25, during the normal decrease in REM sleep shown in humans (Roffwarg et al. 1966) ], whereas unipolar depression in adolescents is very high (Garcia-Rill 1997) . Interestingly, ϳ80% of narcoleptic patients also have a postpubertal age of onset. Narcolepsy is characterized by sudden shifts into unconsciousness and atonia as if these were arousal-triggered episodes of REM sleep. However, we should note that other disorders that are not postpubertal in origin, such as Parkinson's, Huntington's and Alzheimer's diseases, all show increased REM sleep drive, along with anxiety-like deficits in sensory gating and "hypofrontality" (Garcia-Rill 1997 . One group reported that neonates and endogenous depressives have the same distinctive features of baseline REM sleep (Vogel et al. 2000) and suggested that the REM sleep abnormalities of endogenous depression represent an immature, underdeveloped REM sleep system (Vogel et al. 1997) .
It may be possible that the increased REM sleep drive in these disorders represents a regression to a developmental REM sleep state such as that seen soon after birth and may correspond to similar changes in firing that are evident ϳ15 days in the rat. Much additional evidence will be necessary to test this hypothesis. Animal models of disorders that manifest increased REM sleep drive (e.g., models of schizophrenia, depression, or anxiety disorder) would be expected to show increased PPN activity [we were the first to propose that the PPN was overactive in schizophrenia (Karson et al. 1991) and in Parkinson's disease (Teo et al. 1997) ], increased proportions of cells with I h , increased HCN expression, and/or increased acetylcholine release in the thalamus, coupled with decreased release in frontal cortex (i.e., hypofrontality). Different disorders may manifest differential changes in each of these factors among others. Although these are speculative considerations, the basic normative information provided herein regarding the development of morphological and electrophysiological properties of PPN cells is absolutely essential for the future study of dysregulation of this system.
Evolutionary considerations
One question that should be addressed is if the human newborn spends 50% of total sleep time or 33% of the day in REM sleep and the rat newborn spends Ͼ90% of total sleep time or 70% of the day in REM sleep, why is there such a large difference between the two species? Basically, in the human, the decrease in REM sleep becomes a gain in waking time with little change in slow-wave sleep duration. In the rat, the decrease in REM sleep becomes a gain for slow-wave sleep with no change in waking time. The suggestion has been made that, from an evolutiuonary perspective, the more evolved the spe-cies, the more waking time (reviewed in Garcia-Rill 2002). In ontogeny, there is a developmental increase in waking time in the human (Roffwarg et al. 1966) , which mirrors a phylogenetic increase in waking in higher species. In the rat, there is no net gain in waking time in ontogeny (Jouvet-Mounier et al. 1970) as waking duration remains at the same proportion of the day in the adult. We suspect that the critical factor in evolution is not REM sleep duration but waking time duration. Once the developmental role of REM sleep has been served, it may be that it is shed in favor of the most advantageous other state, be it waking in the human or slow-wave sleep in the rat. However, it is this interesting, transient developmental role of REM sleep, and the disturbed development of which could have such dire consequences, that our efforts address. 
